Eupraxia Pharmaceuticals Inc. (EPRX) stock
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.21−0.41 (-6.19%)
Close on Nov 18, 2026Market cap $374.43MP/E –Yield –
Eupraxia Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$28.55M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$28.55M | – |
| FY2024 | Dec 31, 2024 | -$29.99M | – |
| FY2023 | Dec 31, 2023 | -$20.75M | – |
| FY2022 | Dec 31, 2022 | -$14.40M | – |
See a number that looks wrong?